Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Hlevnjak

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Pharmacological Research|July 7, 2012
Anti-inflammatory mechanism of action of azithromycin in LPS-stimulated J774A.1 cellsMihailo Banjanac, Vesna Munić Kos, Krunoslav Nujić, et al.
Breast Care (Basel, Switzerland)|February 22, 2024
Reimbursement in the Context of Precision Oncology Approaches in Metastatic Breast Cancer: Challenges and ExperiencesConstantin Pixberg, Markus Schulze, Lars Buschhorn, et al.
Pharmacological Research|April 9, 2011
Intensity of macrolide anti-inflammatory activity in J774A.1 cells positively correlates with cellular accumulation and phospholipidosisVesna Munić, Mihailo Banjanac, Sanja Koštrun, et al.
International Journal of Cancer|September 15, 2020
Unraveling most abundant mutational signatures in head and neck cancerMichaela Plath, Johanna Gass, Mario Hlevnjak, et al.
Breast Care (Basel, Switzerland)|April 26, 2019
Mismatch Repair Deficiency Drives Durable Complete Remission by Targeting Programmed Death Receptor 1 in a Metastatic Luminal Breast Cancer PatientCarlo Fremd, Mario Hlevnjak, Marc Zapatka, et al.
Journal of Medicinal Chemistry|January 7, 2011
Modeling cellular pharmacokinetics of 14- and 15-membered macrolides with physicochemical propertiesVišnja Stepanić, Sanja Koštrun, Ivica Malnar, et al.
Cancer Research|September 25, 2020
Chromothripsis in Human Breast CancerMichiel Bolkestein, John K L Wong, Verena Thewes, et al.
NPJ Precision Oncology|January 10, 2025
Translational and clinical comparison of whole genome and transcriptome to panel sequencing in precision oncologyIrina A Kerle, Thomas Gross, Anja Kögler, et al.
Nature Communications|November 14, 2018
Defective DNA damage repair leads to frequent catastrophic genomic events in murine and human tumorsManasi Ratnaparkhe, John K L Wong, Pei-Chi Wei, et al.
JCO Precision Oncology|May 26, 2021
CATCH: A Prospective Precision Oncology Trial in Metastatic Breast CancerMario Hlevnjak, Markus Schulze, Shaymaa Elgaafary, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Pharmacological Research|July 7, 2012
Anti-inflammatory mechanism of action of azithromycin in LPS-stimulated J774A.1 cellsMihailo Banjanac, Vesna Munić Kos, Krunoslav Nujić, et al.
Breast Care (Basel, Switzerland)|February 22, 2024
Reimbursement in the Context of Precision Oncology Approaches in Metastatic Breast Cancer: Challenges and ExperiencesConstantin Pixberg, Markus Schulze, Lars Buschhorn, et al.
Pharmacological Research|April 9, 2011
Intensity of macrolide anti-inflammatory activity in J774A.1 cells positively correlates with cellular accumulation and phospholipidosisVesna Munić, Mihailo Banjanac, Sanja Koštrun, et al.
International Journal of Cancer|September 15, 2020
Unraveling most abundant mutational signatures in head and neck cancerMichaela Plath, Johanna Gass, Mario Hlevnjak, et al.
Breast Care (Basel, Switzerland)|April 26, 2019
Mismatch Repair Deficiency Drives Durable Complete Remission by Targeting Programmed Death Receptor 1 in a Metastatic Luminal Breast Cancer PatientCarlo Fremd, Mario Hlevnjak, Marc Zapatka, et al.
Journal of Medicinal Chemistry|January 7, 2011
Modeling cellular pharmacokinetics of 14- and 15-membered macrolides with physicochemical propertiesVišnja Stepanić, Sanja Koštrun, Ivica Malnar, et al.
Cancer Research|September 25, 2020
Chromothripsis in Human Breast CancerMichiel Bolkestein, John K L Wong, Verena Thewes, et al.
NPJ Precision Oncology|January 10, 2025
Translational and clinical comparison of whole genome and transcriptome to panel sequencing in precision oncologyIrina A Kerle, Thomas Gross, Anja Kögler, et al.
Nature Communications|November 14, 2018
Defective DNA damage repair leads to frequent catastrophic genomic events in murine and human tumorsManasi Ratnaparkhe, John K L Wong, Pei-Chi Wei, et al.
JCO Precision Oncology|May 26, 2021
CATCH: A Prospective Precision Oncology Trial in Metastatic Breast CancerMario Hlevnjak, Markus Schulze, Shaymaa Elgaafary, et al.
Pageof 3